Crystal structure of the cu-adduct of human h-ferritin variant 4his-delta c-star Deposition Author(s): Huard, D.J.E. , Tezcan, F.A.
Date: 2012-02-29 Method: X-RAY DIFFRACTION Resolution: 1.85 Å Organism(s): Homo Sapiens Sequences Data: 4DYX_A
Crystal structure of the cu-adduct of human h-ferritin variant mic1 Deposition Author(s): Huard, D.J.E. , Tezcan, F.A.
Date: 2012-02-29 Method: X-RAY DIFFRACTION Resolution: 1.9 Å Organism(s): Homo Sapiens Sequences Data: 4DYY_A
Crystal structure of the apo form of human h-ferritin variant mic1 Deposition Author(s): Huard, D.J.E. , Tezcan, F.A.
Date: 2012-02-29 Method: X-RAY DIFFRACTION Resolution: 2.3 Å Organism(s): Homo Sapiens Sequences Data: 4DYZ_A
Crystal structure of the cu-adduct of human h-ferritin variant mic1 labeled with a dansyl fluorophore Deposition Author(s): Huard, D.J.E. , Tezcan, F.A.
Date: 2012-02-29 Method: X-RAY DIFFRACTION Resolution: 2.5 Å Organism(s): Homo Sapiens Sequences Data: 4DZ0_A
Crystal structure of grp94 bound to methyl 3-chloro-2-(2-(1-((5-chlorofuran-2-yl)methyl)-1h-imidazol-2-yl)ethyl)-4,6-dihydroxybenzoate, an inhibitor based on the bnim and radamide scaffolds. Deposition Author(s): Huard, D.J.E. , Kizziah, J.L. , Lieberman, R.L.
Date: 2016-03-07 Method: X-RAY DIFFRACTION Resolution: 2.6 Å Organism(s): Canis Lupus Familiaris Sequences Data: 5IN9_A , 5IN9_B
Crystal structure of grp94 bound to isoform-selective inhibitor methyl 2-(2-(1-(4-bromobenzyl)-1h-imidazol-2-yl)ethyl)-3-chloro-4,6-dihydroxybenzoate Deposition Author(s): Huard, D.J.E. , Lieberman, R.L.
Date: 2016-11-04 Method: X-RAY DIFFRACTION Resolution: 2.707 Å Organism(s): Canis Lupus Familiaris Sequences Data: 5TTZ_A , 5TTZ_B
Structure of molecular chaperone grp94 bound to selective inhibitor methyl 3-chloro-2-(2-{2-[(4-fluorophenyl)methyl]phenyl}ethyl)-4,6-dihydroxybenzoate Deposition Author(s): Huard, D.J.E. , Lieberman, R.L.
Date: 2017-08-16 Method: X-RAY DIFFRACTION Resolution: 2.764 Å Organism(s): Canis Lupus Familiaris Sequences Data: 6AOL_A
Structure of molecular chaperone grp94 bound to selective inhibitor methyl 2-[2-(2-benzylphenyl)ethyl]-3-chloro-4,6-dihydroxybenzoate Deposition Author(s): Huard, D.J.E. , Lieberman, R.L.
Date: 2017-08-16 Method: X-RAY DIFFRACTION Resolution: 2.87 Å Organism(s): Canis Lupus Familiaris Sequences Data: 6AOM_A , 6AOM_B
Structure of grp94 with methyl 3-chloro-2-(2-(1-(2-ethoxybenzyl)-1 h-imidazol-2-yl)ethyl)-4,6-dihydroxybenzoate, a grp94-selective inhibitor and promising therapeutic lead for treating myocilin-associated glaucoma Deposition Author(s): Huard, D.J.E. , Lieberman, R.L.
Date: 2017-08-25 Method: X-RAY DIFFRACTION Resolution: 2.696 Å Organism(s): Canis Lupus Familiaris Sequences Data: 6ASP_A , 6ASP_B
Structure of grp94 bound to methyl 2-[2-(2-benzylpyridin-3-yl)ethyl]-3-chloro-4,6-dihydroxybenzoate, a pan-hsp90 inhibitor Deposition Author(s): Huard, D.J.E. , Lieberman, R.L.
Date: 2017-08-25 Method: X-RAY DIFFRACTION Resolution: 2.35 Å Organism(s): Canis Lupus Familiaris Sequences Data: 6ASQ_A , 6ASQ_B